John E. Abele discloses 7.88% Beta Technologies (BETA) stake in 13G
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
BETA TECHNOLOGIES, INC. filed a Schedule 13G showing that investor John E. Abele beneficially owns 17,381,082 shares of Class A common stock, representing 7.88% of the class, based on 220,528,649 shares outstanding as of December 1, 2025.
The position includes 30,342 shares issuable from stock options exercisable within 60 days of December 31, 2025, with the remainder held through several affiliated LLCs such as North Point Partner LLC, Harmony Partner Group LLC, and others over which he or his officers may exercise voting and investment discretion.
Positive
- None.
Negative
- None.
FAQ
How much of BETA (BETA) does John E. Abele report owning in this Schedule 13G?
John E. Abele reports beneficial ownership of 17,381,082 BETA Class A shares, equal to 7.88% of the class. This percentage is calculated against 220,528,649 shares outstanding as of December 1, 2025, according to the company’s Form 10-Q.
What type of securities in BETA (BETA) are covered by John E. Abele’s Schedule 13G?
The filing covers BETA’s Class A common stock. Abele’s beneficial ownership includes directly and indirectly held Class A shares, plus 30,342 shares issuable from stock options that are exercisable within 60 days of December 31, 2025.
What ownership threshold does this BETA (BETA) Schedule 13G filing indicate?
The Schedule 13G shows that John E. Abele holds more than 5% of BETA’s Class A common stock, specifically 7.88% of the outstanding shares. Crossing or holding above the 5% level generally triggers Schedule 13D or 13G reporting requirements.
How was the 7.88% ownership figure for BETA (BETA) calculated in the filing?
The 7.88% figure is based on 17,381,082 shares beneficially owned divided by 220,528,649 Class A shares outstanding. That outstanding share count comes from BETA’s Form 10-Q, which reported shares outstanding as of December 1, 2025.